High mobility stem cells and cardiomyopathies by Galli, Daniela et al.
IJAE Vol. 115, n. 1/2 (Supplement), 2010
75
High mobility stem cells and cardiomyopathies
Daniela Galli1, Stefania Crippa2, Maurilio Sampaolesi1, 2
1 Dept of Exp. Med., Human Anatomy Unit, University of Pavia, Italy
2 S.C.R.I., Translational Cardiomyology lab, Katholieke Universiteit of Leuven, Belgium
Dystrophin-associated proteins, including sarcoglycans, are critical for both cardiac 
and skeletal muscle function, probably exerting their roles by different molecular mech-
anisms (Heydemann A et al. 2001). We recently showed that cardiac mesoangioblasts 
(cMabs), derived from beta-sarcoglycan (beta-SG) null hearts, strongly differentiated 
towards a skeletal muscle phenotype forming large myotubes (Crippa et al. 2010). Time-
lapse movies of beta-SG GFP-cMabs evidenced the presence of cell subpopulations char-
acterized by high mobility and incapability to fuse. To isolate these cells, we have sub-
cloned cMabs after 2 rounds of serum starvation. We obtained 5 GFP clones (#7, 11, 17, 
53 and 56). By magnetic beads immunoselection we could separate CD44-cKit positive 
cells from clones. CD44 is a key regulator of myoblast migration (Milona E et al. 2006). 
Then we tested myogenic differentiation potential of the clones eventually co-cultured 
with unlabeled cMabs. Myosin immunofluorescence analysis showed that all the clones 
did not form myotubes. Moreover, 2 of them (#7, #17) seemed to improve myogenic 
potential of unlabeled cMabs. We obtained similar results with C2C12 myoblast cells. 
We have also analysed the cells for expression of stem cell markers. Interestingly, same 
subclones expressed the neural stem cell markers Sox2 and Sox 17.
In summary, we identified a novel cell population able to improve myogenic dif-
ferentiation and potentially able to adopt a neural fate under appropriate culture condi-
tions. Moreover, a recent paper (Stefanovic S et al. 2009) suggests a role for both Sox2 
and Sox 17 in early cardiac differentiation. Thus we are planning to test our clones for 
cardiac differentiation capability in vitro and in vivo.
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